GLANDS
Page 1
Review of the Anatomy and
Physiology of the Adrenal Glands
Page 10
Page 11
Sex hormones
Page 12
Sex hormones
• are usually broken down into three
categories:
1. Androgens, testosterone being the main
one.
2. Estrogens, estradiol being the main one.
3. Progestagens, progesterone being the
main one.
Page 13
Adrenal medulla
• The adrenal medulla is a sympathetic
nerve ganglion that has secretory cells.
The hormones secreted by the adrenal
medulla are called the “fight or flight”
hormones.
• These hormones are under the control of
the sympathetic nervous system. The
adrenal medulla hormones are:
• 1. Epinephrine (also known as adrenaline).
• 2. Norepinephrine (also known as
noradrenaline).
• Epinephrine and norepinephrine together
are referred to as catecholamines.
Page 14
Catecholamines
• a crucial part of the body’s response to stress. The
different actions of catecholamines are to:
– Increase heart rate.
– Cause peripheral blood vessels to constrict so blood
pressure goes up.
– Increase sweating.
– Cause glycogen to convert to glucose (increases
energy).
– Cause bronchial tubes to dilate (to breathe more air
in).
– Decrease digestion (blood is sent to more important
places like your heart).
– Lower urine output (to conserve fluid).
– Increase alertness.
Page 15
Plasma Cortisol
• This is direct measure of the primary
secretory product of the adrenal
cortex by radioimmunoassay
technique.
• Serum concentration varies with
circadian cycle so normal values
vary with time of day and stress level
of patient (8 a.m. levels typically
double that of 8 p.m. levels).
• Useful as an initial step to assess
adrenal dysfunction, but further
workup is usually necessary.
Page 16
Nursing and Patient Care
Considerations
• A fasting sample is preferred.
• Blood specimens should coincide with
circadian rhythm with draw time indicated on
laboratory slip.
• Interpretation of test results:
– Decreased values seen in: adrenal hyperplasia,
Addison's disease, anterior pituitary hyposecretion,
secondary hypothyroidism, hepatitis, and cirrhosis.
– Increased values seen in: hyperthyroidism, stress
(eg, trauma, surgery), carcinoma, Cushing's
syndrome, hypersecretion of corticotropin by
tumors (oat cell cancer), adrenal adenoma, and
obesity.
Page 17
24-Hour Urinary Free
Cortisol Test
• Test measures cortisol
production during a 24-hour
period.
• Useful to establish diagnosis
of hypercortisolism.
• Less influenced by diurnal
variations in cortisol.
Page 18
Nursing and Patient Care
Considerations
• Instruct patient in appropriate
collection technique.
• Collection jug should be kept on ice
and sent to laboratory promptly
when collection completed.
• Interfering factors:
– Elevated values:pregnancy, oral
contraceptives, spironolactone, stress.
– Recent radioisotope scans can
interfere with test results.
Page 19
Dexamethasone Suppression
Test
• The dexamethasone suppression test (DST) is a
valuable method to evaluate adrenal
hyperfunction.
• Adrenal production and secretion of cortisol is
stimulated by adrenocorticotropic hormone
(ACTH, corticotropin) from the pituitary gland.
• Dexamethasone is a synthetic steroid effective
in suppressing corticotropin secretion.
• In a healthy patient, the administration of
dexamethasone will inhibit corticotropin
secretion and will cause cortisol levels to fall
below normal.
Page 20
Nursing and Patient Care
Considerations
• Explain the procedure to the
patient.
– Overnight 1 mg DST (used primarily to
identify those without Cushing's
syndrome).
– High-dose overnight DST (helpful to
distinguish Cushing's disease from
other forms of Cushing's syndrome).
• Encourage patient to take
dexamethasone with milk because
it may cause gastric irritation.
Page 21
Adrenocorticotropic
Stimulation Test
• ACTH stimulates the production
and secretion of cortisol by the
adrenal cortex.
• Demonstrates the ability of the
adrenal cortex to respond
appropriately to ACTH.
• This is an important test to evaluate
adrenal insufficiency, but may not
distinguish primary insufficiency
from secondary insufficiency.
Page 22
Nursing and Patient Care
Considerations
• Obtain baseline cortisol level.
• Administer 0.25 mg ACTH (cosyntropin
[Cortrosyn] I.V. or I.M.).
• Collect cortisol levels at times ordered (usually
at 30 and 60 minutes).
• Interpretation of test results:
– Range of normal responses may vary; however,
typically a rise in cortisol of double baseline value is
considered normal.
– Diminished response—adrenal insufficiency with
low cortisol values, adrenal tumor with high cortisol
values, prolonged glucocorticoid therapy.
– Exaggerated response—adrenal hyperplasia with
high cortisol values.
Page 23
Corticotropin Releasing
Hormone Stimulation Test
• Test measures responsiveness of pituitary
gland to corticotropin-releasing hormone
(CRH), a hypothalamic hormone that
regulates pituitary secretion of ACTH.
• Useful to differentiate the cause of excess
cortisol secretion when ectopic source of
ACTH is suspected.
• In general, CRH will stimulate ACTH
secretion in the pituitary, but not in
nonpituitary corticotropin-secreting
tissues.
Page 24
Nursing and Patient Care
Considerations
• Describe procedure to patient.
– Patient is given CRH (1 mcg/kg or 100 mcg) I.V.
– Catheters are advanced through the femoral veins to areas
near the adrenal glands, so sampling can take place near
ACTH secretion.
– Blood samples for ACTH test are collected at 2, 5, 10, and
15 minutes.
• Normal response is a rise in ACTH to at least double
the baseline value.
• Interpretation of test results:
– Brisk rise in ACTH double baseline value: Cushing's disease.
– No response in ACTH: corticotropin-independent Cushing's
syndrome (adrenal tumor) or ectopic source of corticotropin
secretion (ectopic tumor).
– Test can produce false-negative response.
Page 25
Plasma Catecholamines
Page 26
Clonidine Suppression Test
Page 27
Nursing and Patient Care
Considerations
• Collect baseline catecholamine sample from I.V.
catheter 20 to 30 minutes after venipuncture, if
possible, to reduce the rise in catecholamine levels
from pain and anxiety.
• Give clonidine 0.3 mg orally.
• After 3 hours, collect second catecholamine
sample.
• Interpretation: in patients without
pheochromocytoma, a significant drop in
catecholamines should be seen at 3 hours (less
than 500 pg/mL or reduction of total
catecholamines by 50%), whereas in patients with
pheochromocytoma, no drop in catecholamines
will be evident.
Page 28
Aldosterone (Urine or Blood)
Page 29
Nursing and Patient Care
Considerations
• Test results can be elevated by
stress, strenuous exercise, upright
posture, and medications, such as
diazoxide (Hyperstat), hydralazine
(Apresoline), and nitroprusside
(Nipride).
• Test results may be decreased by
excessive licorice ingestion and the
medications fludrocortisone
(Florinef) and propranolol (Inderal).
Page 30
Page 31
ADDISON’S DISEASE
(ADRENOCORTICAL INSUFFICIENCY)
Page 32
Clinical manifestations:
Page 33
Page 34
Diagnostics:
• Plasma ACTH level
• Decreased serum Na,
increased serum K level
Page 35
Test Results That Suggest Addison's Disease
Test Result
Blood chemistry
Serum Na < 135 mEq/L
Serum K > 5 mEq/L
Ratio of serum Na:K < 30:1
Plasma glucose, fasting < 50 mg/dL (< 2.78
mmol/L)
Plasma HCO3 < 15–20 mEq/L
BUN > 20 mg/dL (> 7.1
mmol/L)
Hematology
Hct Elevated
WBC count Low
Lymphocytes Relative lymphocytosis
Eosinophils Increased
Imaging
Evidence of
Calcification in adrenal
areas
Renal TB
Pulmonary TB Page 36
Nursing and medical
management:
• Initiate and maintain IV infusion of NSS.
• Administer large doses of corticosteroid through
IV bolus initially.
• Monitor V/S.
• Evaluate K level.
• Keep client quiet and immobilized.
• Steroid therapy:
• Give with food
• Check weight daily.
• Increase intake of protein and carbohydrates
• Evaluate for edema and fluid retention
• Risk for infection
• Lifelong steroid therapy especially during
periods of stress.
Page 37
CUSHING’S SYNDROME
Page 38
Clinical manifestations:
• Marked changed in personality.
• Moon face
• Deposit of fat on the back.
• Amenorrhea
• Hirsutism
• Thin skin, purple striae.
• Truncal obesity with thin
extremities.
• Bruises and petechiae
• Persistent hyperglycemia
• GI distress
• Osteoporosis
• Increased susceptibility to infection.
Page 39
Page 40
Page 41
Diagnostics:
• Increased serum Na and
decreased serum K level.
• Hyperglycemia
• Increased plasma cortisol
level.
Page 42
Complications:
• CHF
• HPN
• Pathological fracture
• Psychosis
Page 43
Page 44
Nursing and medical
management:
• Restrict water and sodium intake.
• Monitor fluid and electrolyte level.
• Evaluate for hyperglycemia.
• Prevent infection.
• Monitor for cardiac dysrhythmias.
• Weight bearing exercise
• Adrenalectomy
• Hypophysectomy
• Radiation therapy
Page 45
PHEOCROMOCYTOMA
Risk factors/Etiology:
• Chromaffinoma
• Pregnancy
Page 46
Clinical manifestations:
• SNS overactivity as
manifested by:
• 5 H’s
– Hypertension
– H/A
– Hyperhydrosis
– Hypermetabolism
– Hyperglycemia
Page 47
Diagnostics:
• Serum assay of
catecholamines
• VMA test
Page 48
Nursing and medical
management:
• Bedrest HOB elevated.
• Decrease intake of stimulants.
• Sedate as indicated.
• Maintain calm and quiet environment.
• Assess V/S.
• Anti HPN drug- clonidine, vasodilator
• Monitor for hemorrhagic problems.
• Monitor renal perfusion.
• adrenalectomy
Page 49
Page 50
Page 51
Page 52
• end
Page 53